Changes in exercise capacity in subjects with cardiac asymptomatic hereditary hemochromatosis during a follow-up after 5 yrs

American Journal of Physical Medicine and Rehabilitation

Volumn 91, Issue 5, 2012, Pages 418-424

  Shizukuda, Yukitaka ^a,b,c   Smith, Kevin P ^a   Tripodi, Dorothy J ^a   Arena, Ross ^d   Yau, Yu Ying ^e   Bolan, Charles D ^a   Waclawiw, Myron A ^a   Leitman, Susan F ^e   Rosing, Douglas R ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^e NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Cardiopulmonary Exercise Test; Exercise Capacity; Hereditary Hemochromatosis; Prospective Study

Indexed keywords

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; FOLLOW UP; GENETICS; HEART RATE; HEMOCHROMATOSIS; HUMAN; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; PHLEBOTOMY; PHYSIOLOGY; TIME;

ADULT; AGED; CASE-CONTROL STUDIES; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; FOLLOW-UP STUDIES; HEART RATE; HEMOCHROMATOSIS; HUMANS; MALE; MIDDLE AGED; PHLEBOTOMY; TIME FACTORS;

EID: 84860308680     PISSN: 08949115     EISSN: None     Source Type: Journal    
DOI: 10.1097/PHM.0b013e3182465f5f     Document Type: Article

References (30)

1. Phatak PD, Sham RL, Raubertas RF, et al: Prevalence of hereditary hemochromatosis in 16031 primary care patients. Ann Intern Med 1998;129:954-61 (Pubitemid 28549833)
2. Sham RL, Raubertas RF, Braggins C, et al: Asymptomatic hemochromatosis subjects: genotypic and phenotypic profiles. Blood 2000;96:3707-11
3. Shizukuda Y, Bolan CD, Tripodi DJ, et al: Exercise capacity of cardiac asymptomatic hereditary hemochromatosis subjects. Med Sci Sports Exerc 2007; 39:3-7 (Pubitemid 46095792)
4. Witte DL, Crosby WH, Edwards CQ, et al: Practice guideline development task force of the College of American Pathologists. Hereditary hemochromatosis. Clin Chim Acta 1996;245:139-200 (Pubitemid 2625162)
5. Chicharro JL, Hoyos J, Gomez-Gallego F, et al: Mutations in the hereditary haemochromatosis gene HFE in professional endurance athletes. Br J Sports Med 2004;38:418-21 (Pubitemid 39044020)
6. Vautier G, Murray M, Olynyk JK: Hereditary haemochromatosis: Detection and management. Med J Aust 2001;175:418-21 (Pubitemid 32982213)
7. Dolbey CH: Hemochromatosis: A review. Clin J Oncol Nurs 2001;5:257-60
8. Bothwell TH, MacPhail AP: Hereditary hemochromatosis: Etiologic, pathologic, and clinical aspects. Semin Hematol 1998;35:55-71 (Pubitemid 28047042)
9. World Medical Association: World Medical Association declaration of Helsinki. Recommendations guiding physicians in biomedical research involving human subjects. JAMA 1997;277:925-6
10. Dooley JS, Walker AP: Genetic hemochromatosis: Detection, management, and population screening. Genet Test 2000;4:97-101 (Pubitemid 30618694)
11. Barton JC, Adams PC: Clinical guidelines: HFE hemochromatosis-screening, diagnosis and management. Nat Rev Gastroenterol Hepatol 2010;7:482-4
12. Bruce RA: Methods of exercise testing. Step test, bicycle, treadmill, isometrics. Am J Cardiol 1974;33: 715-20
13. Weber KT, Janicki JS, McElroy PA: Determination of aerobic capacity and the severity of chronic cardiac and circulatory failure. Circulation 1987;76: VI40-5
14. Simonton CA, Higginbotham MB, Cobb FR: The ventilatory threshold: Quantitative analysis of reproducibility and relation to arterial lactate concentration in normal subjects and in patients with chronic congestive heart failure. Am J Cardiol 1988;62:100-7
15. Jones NL, Markrides L, Hitchcock C, et al: Normal standars for an incremental progressive cycle ergometer test. Am Rev Respir Dis 1985;129:S49-55
16. Beaver WL, Wasserman K, Whipp BJ: A new method for detecting anaerobic threshold by gas exchange. J Appl Physiol 1986;60:2020-7 (Pubitemid 16066969)
17. Arena R, Myers J, Aslam SS, et al: Peak V+ O2 and V+ E/ V+ CO2 slope in patients with heart failure: A prognostic comparison. Am Heart J 2004;147:354-60 (Pubitemid 38176838)
18. Chua TP, Ponikowski P, Harrington D, et al: Clinical correlates and prognostic significance of the ventilatory response to exercise in chronic heart failure. J Am Coll Cardiol 1997;29:1585-90 (Pubitemid 27272454)
19. Kleber FX, Vietzke G, Wernecke KD, et al: Impairment of ventilatory efficiency in heart failure: Prognostic impact. Circulation 2000;101:2803-9 (Pubitemid 30396010)
20. Davis JA, Sorrentino KM, Ninness EM, et al: Testretest reliability for two indices of ventilatory efficiency measured during cardiopulmonary exercise testing in healthy men and women. Clin Physiol Funct Imaging 2006;26:191-6
21. Balady GJ, Arena R, Sietsema K et al: Clinician's guide to cardiopulmonary exercise testing in adults. A scientific statement from the American Heart Association. Circulation 2010;122:191-225
22. Habedank D, Reindl I, Vietzke G, et al: Ventilatory efficiency and exercise tolerance in 101 healthy volunteers. Eur J Appl Physiol Occup Physiol 1998;77: 421-6 (Pubitemid 28154147)
23. Goraya TY, Jacobsen SJ, Pellikka PA, et al: Prognostic value of treadmill exercise testing in elderly persons. Ann Intern Med 2000;132:862-70 (Pubitemid 30346848)
24. Leitman SF, Browning JN, Yau YY, et al: Hemochromatosis subjects as allogeneic blood donors: A prospective study. Transfusion 2003;43:1538-44 (Pubitemid 37371823)
25. Shizukuda Y, Bolan, CD, Tripodi, DJ, et al: Left ventricular systolic function during stress echocardigraphy exercise in subjects with asymptomatic hereditary hemochromatosis. Am J Cardiol 2006;98:694-8 (Pubitemid 44233473)
26. Olson LJ, Baldus WP, Tajik AJ: Echocardiographic features of idiopathic hemochromatosis. Am J Cardiol 1987;60:885-9 (Pubitemid 17163453)
27. Dabestani A, Child JS, Perloff JK, et al: Cardiac abnormalities in primary hemochromatosis. Ann N Y Acad Sci 1988;526:234-44
28. Palka P, Macdonald G, Lange A, Burstow DJ: The role of Doppler left ventricular filling indexes and Doppler tissue echocardiography in the assessment of cardiac involvement in hereditary hemochromatosis. J Am Soc Echocardiogr 2002;15:884-90
29. Shizukuda Y, Bolan CD, Nguyen TT, et al: Oxidative stress in asymptomatic subjects with hereditary hemochromatosis. Am J Hematol 2007;82:249-50 (Pubitemid 46363804)
30. Shizukuda Y, Bolan CD, Tripodi DJ, et al: Does oxidative stress modulate left ventricular diastolic function in asymptomatic subjects with hereditary hemochromatosis? Echocardiography 2009;26:1153-8